×
Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As

Can Ozempic Treat Alcoholism? Here’s What You Should Know

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders.

Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders.

Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

Source link
#Ozempic #Treat #Alcoholism #Heres


Not so long ago, the name Midjourney was synonymous with AI imagery. (Remember that brief period when everyone you knew was using an AI-generated selfie on social media?) Now the company is attempting to rebrand itself as a wellness brand.

In a blog post published Wednesday, titled “A New Era for Midjourney,” the company described its plans for a new project, which it said is “a little weird and a little crazy, but also spectacular and filled with hope.” For starters, it’s working on a body scanner technology, which it says will be faster, cheaper, and less invasive than an MRI. The experience they have in mind sounds like a blend between Han Solo being lowered into the pit at Jabba’s Palace before getting blasted with carbonite and an ayahuasca trip report. Here’s how Midjourney describes it in their blog post:

It starts by stepping into a shallow pool of golden light. You then begin to descend into the water. Your body passes through a ring of underwater sensors, each acting like a dolphin, using its echolocation. The sensors send ultrasonic sound waves through your body from every angle. With enough waves, and enough angles, we form an image of what’s happening inside your body.

All of this should take no more than a minute, the blog post added.

Midjourney envisions a ring of half a million sensors within the scanner, each about the size of a grain of sand, blasting ultrasonic waves at your body and using the reverberations to create a detailed 3-D map of what’s happening inside. “Envisions” is the key word, there: The announcement didn’t make clear what stage of R&D the scanner is currently in, but it did admit that the company still needs to figure out a “major computational task,” namely, how to transform all those noisy waves into static images.

The process will reportedly harvest “terabytes of data each second,” based on the idea that the more information you collect about your body, the clearer and more complete a picture you can build of your individual health profile.

“You want as much data as you can get about your health as quickly and as cheaply as possible,” the company wrote. “In other words, you want a technology optimized for getting as many megabytes per second per dollar of information about your body.”

Midjourney is going to great lengths to contrast its body scanner with MRIs, which—as anyone who’s had to go into one will already know—aren’t particularly comfortable. In fact, the company is going so far as to make its scanning technology the centerpiece of a new spa, which it plans to open in downtown San Francisco before the end of next year.

It’s here that the “a little weird” part starts to feel like a pretty monumental understatement. The Midjourney Spa, as it’s being called, will have the typical accouterments of a high-end spa, like hot tubs and cold plunges, along with “cozy rooms with pools of golden light which softly scan your body.” Midjourney says the spa will be open 24/7 and will be so comfortable, so inviting, as to make guests almost completely forget about the fact that their insides are being scanned by millions of tiny, ultrasonic sensors.

“The scans are a side-effect,” the company wrote. “You barely think of them when going to the spa. But suddenly, you have a huge library of data about your health.”

The announcement added that Midjourney aims to open additional spas in more cities beginning in 2028, and that the company’s next step will be to submit early test results from its body-scanning device to the FDA in the hopes of getting regulatory clearance to build devices with “increased capabilities.”

#Remember #Midjourney #Building #Medical #Scanning #Device #Cheaper #MRIAI,AI images,Health,Midjourney,San Francisco">Remember Midjourney? It’s Building a Medical Scanning Device That It Says Is Cheaper Than an MRI
                Not so long ago, the name Midjourney was synonymous with AI imagery. (Remember that brief period when everyone you knew was using an AI-generated selfie on social media?) Now the company is attempting to rebrand itself as a wellness brand. In a blog post published Wednesday, titled “A New Era for Midjourney,” the company described its plans for a new project, which it said is “a little weird and a little crazy, but also spectacular and filled with hope.” For starters, it’s working on a body scanner technology, which it says will be faster, cheaper, and less invasive than an MRI. The experience they have in mind sounds like a blend between Han Solo being lowered into the pit at Jabba’s Palace before getting blasted with carbonite and an ayahuasca trip report. Here’s how Midjourney describes it in their blog post: It starts by stepping into a shallow pool of golden light. You then begin to descend into the water. Your body passes through a ring of underwater sensors, each acting like a dolphin, using its echolocation. The sensors send ultrasonic sound waves through your body from every angle. With enough waves, and enough angles, we form an image of what’s happening inside your body. All of this should take no more than a minute, the blog post added. Midjourney envisions a ring of half a million sensors within the scanner, each about the size of a grain of sand, blasting ultrasonic waves at your body and using the reverberations to create a detailed 3-D map of what’s happening inside. “Envisions” is the key word, there: The announcement didn’t make clear what stage of R&D the scanner is currently in, but it did admit that the company still needs to figure out a “major computational task,” namely, how to transform all those noisy waves into static images. The process will reportedly harvest “terabytes of data each second,” based on the idea that the more information you collect about your body, the clearer and more complete a picture you can build of your individual health profile.

 “You want as much data as you can get about your health as quickly and as cheaply as possible,” the company wrote. “In other words, you want a technology optimized for getting as many megabytes per second per dollar of information about your body.”

 Midjourney is going to great lengths to contrast its body scanner with MRIs, which—as anyone who’s had to go into one will already know—aren’t particularly comfortable. In fact, the company is going so far as to make its scanning technology the centerpiece of a new spa, which it plans to open in downtown San Francisco before the end of next year. It’s here that the “a little weird” part starts to feel like a pretty monumental understatement. The Midjourney Spa, as it’s being called, will have the typical accouterments of a high-end spa, like hot tubs and cold plunges, along with “cozy rooms with pools of golden light which softly scan your body.” Midjourney says the spa will be open 24/7 and will be so comfortable, so inviting, as to make guests almost completely forget about the fact that their insides are being scanned by millions of tiny, ultrasonic sensors.

 “The scans are a side-effect,” the company wrote. “You barely think of them when going to the spa. But suddenly, you have a huge library of data about your health.” The announcement added that Midjourney aims to open additional spas in more cities beginning in 2028, and that the company’s next step will be to submit early test results from its body-scanning device to the FDA in the hopes of getting regulatory clearance to build devices with “increased capabilities.”      #Remember #Midjourney #Building #Medical #Scanning #Device #Cheaper #MRIAI,AI images,Health,Midjourney,San Francisco

blog post published Wednesday, titled “A New Era for Midjourney,” the company described its plans for a new project, which it said is “a little weird and a little crazy, but also spectacular and filled with hope.” For starters, it’s working on a body scanner technology, which it says will be faster, cheaper, and less invasive than an MRI. The experience they have in mind sounds like a blend between Han Solo being lowered into the pit at Jabba’s Palace before getting blasted with carbonite and an ayahuasca trip report. Here’s how Midjourney describes it in their blog post:

It starts by stepping into a shallow pool of golden light. You then begin to descend into the water. Your body passes through a ring of underwater sensors, each acting like a dolphin, using its echolocation. The sensors send ultrasonic sound waves through your body from every angle. With enough waves, and enough angles, we form an image of what’s happening inside your body.

All of this should take no more than a minute, the blog post added.

Midjourney envisions a ring of half a million sensors within the scanner, each about the size of a grain of sand, blasting ultrasonic waves at your body and using the reverberations to create a detailed 3-D map of what’s happening inside. “Envisions” is the key word, there: The announcement didn’t make clear what stage of R&D the scanner is currently in, but it did admit that the company still needs to figure out a “major computational task,” namely, how to transform all those noisy waves into static images.

The process will reportedly harvest “terabytes of data each second,” based on the idea that the more information you collect about your body, the clearer and more complete a picture you can build of your individual health profile.

“You want as much data as you can get about your health as quickly and as cheaply as possible,” the company wrote. “In other words, you want a technology optimized for getting as many megabytes per second per dollar of information about your body.”

Midjourney is going to great lengths to contrast its body scanner with MRIs, which—as anyone who’s had to go into one will already know—aren’t particularly comfortable. In fact, the company is going so far as to make its scanning technology the centerpiece of a new spa, which it plans to open in downtown San Francisco before the end of next year.

It’s here that the “a little weird” part starts to feel like a pretty monumental understatement. The Midjourney Spa, as it’s being called, will have the typical accouterments of a high-end spa, like hot tubs and cold plunges, along with “cozy rooms with pools of golden light which softly scan your body.” Midjourney says the spa will be open 24/7 and will be so comfortable, so inviting, as to make guests almost completely forget about the fact that their insides are being scanned by millions of tiny, ultrasonic sensors.

“The scans are a side-effect,” the company wrote. “You barely think of them when going to the spa. But suddenly, you have a huge library of data about your health.”

The announcement added that Midjourney aims to open additional spas in more cities beginning in 2028, and that the company’s next step will be to submit early test results from its body-scanning device to the FDA in the hopes of getting regulatory clearance to build devices with “increased capabilities.”

#Remember #Midjourney #Building #Medical #Scanning #Device #Cheaper #MRIAI,AI images,Health,Midjourney,San Francisco">Remember Midjourney? It’s Building a Medical Scanning Device That It Says Is Cheaper Than an MRIRemember Midjourney? It’s Building a Medical Scanning Device That It Says Is Cheaper Than an MRI
                Not so long ago, the name Midjourney was synonymous with AI imagery. (Remember that brief period when everyone you knew was using an AI-generated selfie on social media?) Now the company is attempting to rebrand itself as a wellness brand. In a blog post published Wednesday, titled “A New Era for Midjourney,” the company described its plans for a new project, which it said is “a little weird and a little crazy, but also spectacular and filled with hope.” For starters, it’s working on a body scanner technology, which it says will be faster, cheaper, and less invasive than an MRI. The experience they have in mind sounds like a blend between Han Solo being lowered into the pit at Jabba’s Palace before getting blasted with carbonite and an ayahuasca trip report. Here’s how Midjourney describes it in their blog post: It starts by stepping into a shallow pool of golden light. You then begin to descend into the water. Your body passes through a ring of underwater sensors, each acting like a dolphin, using its echolocation. The sensors send ultrasonic sound waves through your body from every angle. With enough waves, and enough angles, we form an image of what’s happening inside your body. All of this should take no more than a minute, the blog post added. Midjourney envisions a ring of half a million sensors within the scanner, each about the size of a grain of sand, blasting ultrasonic waves at your body and using the reverberations to create a detailed 3-D map of what’s happening inside. “Envisions” is the key word, there: The announcement didn’t make clear what stage of R&D the scanner is currently in, but it did admit that the company still needs to figure out a “major computational task,” namely, how to transform all those noisy waves into static images. The process will reportedly harvest “terabytes of data each second,” based on the idea that the more information you collect about your body, the clearer and more complete a picture you can build of your individual health profile.

 “You want as much data as you can get about your health as quickly and as cheaply as possible,” the company wrote. “In other words, you want a technology optimized for getting as many megabytes per second per dollar of information about your body.”

 Midjourney is going to great lengths to contrast its body scanner with MRIs, which—as anyone who’s had to go into one will already know—aren’t particularly comfortable. In fact, the company is going so far as to make its scanning technology the centerpiece of a new spa, which it plans to open in downtown San Francisco before the end of next year. It’s here that the “a little weird” part starts to feel like a pretty monumental understatement. The Midjourney Spa, as it’s being called, will have the typical accouterments of a high-end spa, like hot tubs and cold plunges, along with “cozy rooms with pools of golden light which softly scan your body.” Midjourney says the spa will be open 24/7 and will be so comfortable, so inviting, as to make guests almost completely forget about the fact that their insides are being scanned by millions of tiny, ultrasonic sensors.

 “The scans are a side-effect,” the company wrote. “You barely think of them when going to the spa. But suddenly, you have a huge library of data about your health.” The announcement added that Midjourney aims to open additional spas in more cities beginning in 2028, and that the company’s next step will be to submit early test results from its body-scanning device to the FDA in the hopes of getting regulatory clearance to build devices with “increased capabilities.”      #Remember #Midjourney #Building #Medical #Scanning #Device #Cheaper #MRIAI,AI images,Health,Midjourney,San Francisco

Not so long ago, the name Midjourney was synonymous with AI imagery. (Remember that brief period when everyone you knew was using an AI-generated selfie on social media?) Now the company is attempting to rebrand itself as a wellness brand.

In a blog post published Wednesday, titled “A New Era for Midjourney,” the company described its plans for a new project, which it said is “a little weird and a little crazy, but also spectacular and filled with hope.” For starters, it’s working on a body scanner technology, which it says will be faster, cheaper, and less invasive than an MRI. The experience they have in mind sounds like a blend between Han Solo being lowered into the pit at Jabba’s Palace before getting blasted with carbonite and an ayahuasca trip report. Here’s how Midjourney describes it in their blog post:

It starts by stepping into a shallow pool of golden light. You then begin to descend into the water. Your body passes through a ring of underwater sensors, each acting like a dolphin, using its echolocation. The sensors send ultrasonic sound waves through your body from every angle. With enough waves, and enough angles, we form an image of what’s happening inside your body.

All of this should take no more than a minute, the blog post added.

Midjourney envisions a ring of half a million sensors within the scanner, each about the size of a grain of sand, blasting ultrasonic waves at your body and using the reverberations to create a detailed 3-D map of what’s happening inside. “Envisions” is the key word, there: The announcement didn’t make clear what stage of R&D the scanner is currently in, but it did admit that the company still needs to figure out a “major computational task,” namely, how to transform all those noisy waves into static images.

The process will reportedly harvest “terabytes of data each second,” based on the idea that the more information you collect about your body, the clearer and more complete a picture you can build of your individual health profile.

“You want as much data as you can get about your health as quickly and as cheaply as possible,” the company wrote. “In other words, you want a technology optimized for getting as many megabytes per second per dollar of information about your body.”

Midjourney is going to great lengths to contrast its body scanner with MRIs, which—as anyone who’s had to go into one will already know—aren’t particularly comfortable. In fact, the company is going so far as to make its scanning technology the centerpiece of a new spa, which it plans to open in downtown San Francisco before the end of next year.

It’s here that the “a little weird” part starts to feel like a pretty monumental understatement. The Midjourney Spa, as it’s being called, will have the typical accouterments of a high-end spa, like hot tubs and cold plunges, along with “cozy rooms with pools of golden light which softly scan your body.” Midjourney says the spa will be open 24/7 and will be so comfortable, so inviting, as to make guests almost completely forget about the fact that their insides are being scanned by millions of tiny, ultrasonic sensors.

“The scans are a side-effect,” the company wrote. “You barely think of them when going to the spa. But suddenly, you have a huge library of data about your health.”

The announcement added that Midjourney aims to open additional spas in more cities beginning in 2028, and that the company’s next step will be to submit early test results from its body-scanning device to the FDA in the hopes of getting regulatory clearance to build devices with “increased capabilities.”

#Remember #Midjourney #Building #Medical #Scanning #Device #Cheaper #MRIAI,AI images,Health,Midjourney,San Francisco

Samsung The Frame Pro 2026: The Best Art Television You Can BuyOn the Netflix show Legends, AI processing was used to enhance a dimly lit office scene to bring up the contrast. I had a similar experience watching scenes from Awake on Netflix, which takes place mostly at night. I could still see the main characters even in darker areas of the scene. YouTube videos of WIRED interviews looked clear and colorful as well. In comparison, low-cost televisions seem more like a computer display with stark bright colors playing the same clips.Samsung also leveraged AI to improve sound quality. In time for the World Cup, Samsung’s new AI audio feature helps enhance the volume of the broadcaster voices while lowering distracting crowd noises when watching soccer matches. For movies, the AI Sound Controller Pro sliders can help boost voices and reduce the volume of background music, but the experience is still buggy. While I could adjust the sliders, they’d always revert back to the default settings. Still, with Dolby Atmos support, I found myself immersed in the experience as audio emanated from around the room when watching Unbroken.There were also several glitches I’ve noticed in testing. AirPlay worked fine, but when trying to use Google Cast to stream Alien: Romulus on HBO Max from my Android phone, an error occurred. Cloud gaming on GeForce NOW also presented with a bug that prevented me from authenticating with the service. Samsung reps are looking into these issues.Despite the bugs, I’m convinced that The Frame Pro is a capable gaming display. Gamers looking to connect a console or gaming PC can use the Mini HDMI port on the rear of the television or the Wireless One Connect box. Both support refresh rates up to 240 Hz. I’m not a competitive gamer, so I stuck with the breakout box to connect my PC. I was amazed at Crimson Desert’s stutter-free performance. Everything looked rich and vibrant—there were also no delays using an Xbox controller.I also tested the Aphelion using the Xbox Cloud Gaming app for console-free gaming. Other than slight stuttering due to lag, it all worked fine. Senua’s Saga: Hellblade II, a game that typically looks washed out on some competing TVs and projectors, appears vibrant on the screen.The Frame Pro 2026 is an exceptional art television, and it’s among the best I’ve tested. Improvements to the Tizen OS, matte finish with anti-glare coating, and AI enhancements make it even more appealing. My only slight pause is the price. The Amazon Ember Artline also looks stunning and costs about 0 less. But The Frame Pro is the one you want for absolute realism and vivid colors.#Samsung #Frame #Pro #Art #Television #Buysamsung,review,televisions,tv,shopping

Post Comment